Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HILO: Hizentra Higher Infusion Parameters Study
NCT03033745Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Feb 2017
- Primary completion
- Dec 2018
- Modality
- Biologic
- Countries
- 2
01
Overview
A Phase 4 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Feb 2017; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT03033745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03033745.